Pitcairn Co. Sells 11,556 Shares of CVS Health Co. (NYSE:CVS)

Pitcairn Co. lowered its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 60.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,598 shares of the pharmacy operator's stock after selling 11,556 shares during the quarter. Pitcairn Co.'s holdings in CVS Health were worth $478,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the third quarter worth about $25,000. Livelsberger Financial Advisory purchased a new position in shares of CVS Health during the third quarter valued at approximately $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health in the 3rd quarter worth approximately $32,000. First Community Trust NA increased its position in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after buying an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. purchased a new position in CVS Health during the third quarter valued at $33,000. Institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CVS. Royal Bank of Canada reduced their price target on CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a report on Friday, November 15th. Wells Fargo & Company upgraded shares of CVS Health from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. UBS Group raised their price target on shares of CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research report on Thursday, November 7th. Evercore ISI upped their price objective on CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research report on Tuesday, October 8th. Finally, StockNews.com lowered CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have assigned a buy rating to the company's stock. According to data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and a consensus target price of $70.33.

CVS Health Stock Performance

Shares of NYSE:CVS traded up $0.95 during midday trading on Wednesday, hitting $59.96. The company had a trading volume of 7,596,294 shares, compared to its average volume of 11,346,436. The company has a market cap of $75.45 billion, a price-to-earnings ratio of 15.22, a PEG ratio of 1.01 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a fifty day moving average of $59.30 and a two-hundred day moving average of $58.72. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.21 earnings per share. On average, equities research analysts expect that CVS Health Co. will post 5.43 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.44%. CVS Health's payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.